论文部分内容阅读
本文试图分析连续酶检查在确定急性心肌梗死的预后和并发症发生率中的价值。研究方法:对125例急性心肌梗死患者同时作血清谷草转氨酶(SGOT)、乳酸脱氢酶(LDH)、磷酸肌酸激酶(CPK)和羟丁酸脱氢酶(HBD)分析。在心肌梗死后头4天和第5、7、10天作酶测定。心肌梗死后每天作心电图检查。根据观察到的并发症,125例可分为5组:(1)在住院后开始5～7天期间发生一次以上明显心律失常者(79例);(2)有心源性休克但无其他并发症者(7例);(3)有心力衰竭者(17例);(4)有心律失常、心力衰竭和心源性休克
This article attempts to analyze the value of sequential enzyme assays in determining the prognosis and the incidence of complications in acute myocardial infarction. Methods: Serum aspartate aminotransferase (SGOT), lactate dehydrogenase (LDH), creatine phosphokinase (CPK) and hydroxybutyrate dehydrogenase (HBD) were assayed in 125 patients with acute myocardial infarction. In the first 4 days after myocardial infarction and the 5th, 7th, 10th day for enzyme determination. ECG after myocardial infarction every day. According to the observed complications, 125 patients were divided into 5 groups: (1) those who had obvious arrhythmia more than once during the first 5 to 7 days after hospitalization (79 cases); (2) cardiogenic shock but no other complications (7 cases); (3) heart failure (17 cases); (4) arrhythmia, heart failure and cardiogenic shock